source
- U.S. drafts new investment rules to keep pharma licensing deals with China viableThe United States is drafting new guidelines that would govern how American investors can fund Chinese biotech and pharmaceutical companies. The proposed framework is intended to address national‑s…
- Alkermes reports promising Phase 1b results for orexin agonist ALKS 7290 in ADHDAlkermes presented data from a Phase 1b study that evaluated its orexin-based compound ALKS 7290 in adults with attention-deficit/hyperactivity disorder. The trial enrolled 50 participants who rece…